Allograft Dysfunction in Heart Transplant
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorPaul Kim
About this trial
The investigators will evaluate for early evidence of cardiac allograft dysfunction by cardiac MRI and single cell sequencing to determine underlying molecular and macroscopic causes.
Eligibility criteria
Qualifiers
Age greater than or equal to 18 years old.
At least three months status post heart transplantation.
Disqualifiers
Biopsy proven acute rejection episode in the past 3 months.
Patients with symptoms or signs of acute myocardial ischemia or recent acute coronary syndrome in the past 3 months.
Uncontrolled obstructive ventilatory disease including asthma and COPD.
History of generalized tonic-clonic seizures.
Trial design
Treatments tested in this trial
- Regadenoson
Treatment groups
376 Participants
are divided into 4 treatment groupsSponsors and collaborators
Paul Kim
Lead sponsor
University of California, San Diego
Sponsor institution
Source ClinicalTrials.gov